BioSpace News Archive

Virtual Panel of Nephrology Care Professionals to Share Insights and Experiences Managing Hyperphosphatemia in Patients with Chronic Kidney Disease on Dialysis [09-December-2020] CAMBRIDGE, Mass. , Dec. 9, 2020 /PRNewswire/ -- Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disea

Nationwide survey believed to be the first to reveal insights into U.S. consumer behaviors and attitudes toward COVID-19 testing and health effects since fall-winter COVID-19 wave began

Charles River Laboratories International, Inc. (NYSE: CRL) today announced that it is the first company to offer clients Good Laboratory Practices (GLP) validated digital peer review using Deciphex Patholytix Preclinical for toxicologic pathology. Through its partnership with Deciphex

Whole antibodies have grabbed a significant share of the global sales revenue as well as the volume of the biopharmaceuticals market.

Hemodialysis is a process that uses artificial membrane to remove waste, such as urea, from the blood, restore proper balance of electrolytes in the blood, and eliminate extra fluid from the body.

Hyaluronidase are enzymes that catalyze the degradation of hyaluronic acid. These enzymes are widely employed in esthetic medicine.

The global market for sickle cell disease treatment has been expanding on account of advancements in the field of anemia treatment.

Pet noise anxiety can be triggered by loud noises such as fireworks, thunderstorms, gunshots, Sirens and Construction Noises.

BD, a leading global medical technology company, announced publication of the results from a 52-subject human clinical trial with the BD Libertas™ Wearable Injector.

Patients Difficult to Wean From Invasive Mechanical Ventilation Showed Over Three Hundred Percent Greater Improvement in Maximal Inspiratory Pressure Using Novel Diaphragm Stimulation Therapy